Since skeletal muscle accounts for 80% of insulin-stimulated glucose disposal, and that obesity is associated with increasing insulin resistance in muscle tissue (55, 56), maintaining muscle mass while reducing total fat and VAT should always be advised when loss of weight is recommended. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.